InvestorsHub Logo

Ubertino

02/04/14 1:48 PM

#79595 RE: daBoze #79594

Money never hurts!

If I was the FDA (!!!), and needed input about viruses I would seek out Erasmus!

Puffer

02/04/14 1:50 PM

#79596 RE: daBoze #79594

I think probably an expedited path.

ZincFinger

02/04/14 2:05 PM

#79598 RE: daBoze #79594

They said they wanted to move more targets ahead more quickly. I suspect that there may have been some delay(s) elsewhere based on the existing queues for BSL 3 labs. In addition to having it's own BSL 3 labs, Viroclinics offers an broad range of services for all stages of development for moving a drug thru to approval. IMHO things will be happening a lot faster as a result of this move.